Non-obstructive urinary retention (NOR) Overactive bladder (OAB)
Conditions
Interventions
After inclusion and informed consent, patients will fill out a baseline voiding
diary throughout seven days. The 28 day test stimulation period starts on the
day of the first tined lead procedure. O
Sponsors
Medisch Universitair Ziekenhuis Maastricht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: Patients should have been diagnosed with overactive bladder syndrome or non-obstructive urinary retention and should be put on the waiting list for scheduling treatment with sacral neuromodulation.
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: a) patients receiving neurological or psychiatric medication without being diagnosed with a neurological or psychiatric disease; b) patients who have been treated by means of bladder wall botuline toxine injections in the past twelve months; c) patients with evident subsequent complains of bladder pain syndrome or other pelvic pain.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The transition point between no effect and time of onset is determined by assessing when symptoms are reduced by 50% compared to baseline. Vice versa for time of offset. Time of on set and offset will be assessed in days (24 hours). | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicable. | — |
Countries
Netherlands
Outcome results
None listed